Articles

• Bortezomib: introduction

  Alessandro Corso

  https://doi.org/10.4081/hmr.v2i5.379

  285

  PDF: 255

  • PDF

• An update of the apex study

  Alessandro Corso

  https://doi.org/10.4081/hmr.v2i5.380

  315

  PDF: 1347

  • PDF

• Bortezomib-combination based therapy in relapsed-refractory myeloma patients

  Patrizia Zappasodi

  https://doi.org/10.4081/hmr.v2i5.381

  255

  PDF: 1386

  • PDF

• Bortezomib in newly diagnosed multiple myeloma patients

  Silvia Mangiacavalli

  https://doi.org/10.4081/hmr.v2i5.382

  198

  PDF: 316

  • PDF

• Frequency and characteristics of hematologic and non-hematologic Bortezomib-related toxicity

  Marzia Varettoni

  https://doi.org/10.4081/hmr.v2i5.383

  203

  PDF: 1675

  • PDF